Aelis Farma: Funding, Investors & Team (Sep 2026)
Aelis Farma is a biotech company that develops pharmaceutical therapies that target chronic and neurodegenerative diseases by modulating immune and inflammatory pathways. The company focuses on advancing novel drug candidates designed to slow or halt the progression of conditions such as Alzheimer’s disease and other central nervous system disorders. Its pipeline includes small molecules that aim to engage specific biological targets associated with disease pathology, with the objective of producing measurable changes in biomarkers and clinical outcomes. The organization’s research strategy centers on understanding disease mechanisms and translating that knowledge into therapeutic candidates that address unmet medical needs. Aelis Farma conducts preclinical studies and clinical trials to evaluate safety, efficacy, dosing, and biological activity of its compounds, collaborating with scientific institutions and clinical researchers throughout the development process.
Aelis Farma has raised $530k across 1 funding round on record, the most recent an undisclosed round of $530k announced in Apr 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aelis Farma Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Aelis Farma Funding Rounds
Aelis Farma Founders and Leadership Team
No contact details are on record for this team yet.
Aelis Farma Funding Compared to Other Biotechnology Startups
Aelis Farma's latest round of $530k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aelis Farma in Biotechnology and Bordeaux
Companies Similar to Aelis Farma
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Aelis Farma Funding FAQs
What does Aelis Farma do?
Aelis Farma is a biotech company that develops pharmaceutical therapies that target chronic and neurodegenerative diseases by modulating immune and inflammatory pathways. The company focuses on advancing novel drug candidates designed to slow or halt the progression of conditions such as Alzheimer’s disease and other central nervous system disorders. Its pipeline includes small molecules that aim to engage specific biological targets associated with disease pathology, with the objective of producing measurable changes in biomarkers and clinical outcomes. The organization’s research strategy centers on understanding disease mechanisms and translating that knowledge into therapeutic candidates that address unmet medical needs. Aelis Farma conducts preclinical studies and clinical trials to evaluate safety, efficacy, dosing, and biological activity of its compounds, collaborating with scientific institutions and clinical researchers throughout the development process.
How much funding has Aelis Farma raised?
Aelis Farma has raised $530k across 1 round on record. The most recent is an undisclosed round of $530k announced in Apr 2026.
When did Aelis Farma last raise funding?
Aelis Farma's most recent funding round on record is an undisclosed round of $530k, announced in Apr 2026.
Who founded Aelis Farma?
FundedIQ lists Pier Vincenzo (Founder) at Aelis Farma.
Where is Aelis Farma headquartered?
Aelis Farma is based in Bordeaux, Aquitaine, France.
How many employees does Aelis Farma have?
Aelis Farma is in the 11-50 employee band.
How does Aelis Farma's funding compare to other Biotechnology startups?
Aelis Farma's latest round of $530k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Aelis Farma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aelis Farma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.